Evaluation of Biochemical Markers and Clinical Outcomes in Snakebite Envenomation Patients in Mardan, Pakistan: A Hospital-Based Study
DOI:
https://doi.org/10.59736/IJP.24.03.1097Keywords:
Acute Kidney Injury, Biochemical Markers, Clinical Outcomes, Coagulopathy, Snakebite EnvenomationAbstract
Background: Snakebite envenomation is a public health problem with significant morbidity and mortality in developing countries especially in the rural population and is affected by delays in seeking health care. Biochemistry may be useful in predicting the disease's severity and outcomes. This study aims to assess biochemical parameters and clinical outcomes in snakebite envenomation patients and determine the risk factors for adverse outcomes.
Methods: The study was descriptive in nature and it was conducted at MTI-Mardan Medical Complex, Pakistan. All 91 adult patients with clinically suspected snake bite envenomation were selected by non-probability consecutive sampling. A structured proforma was used to collect the demographic, clinical, laboratory, treatment and outcome data. Laboratory investigations consisted of full blood count, coagulation profile, renal function tests, electrolyte levels and creatine kinase levels. The data were analyzed with SPSS version 25 and association tested by Chi-square or Fisher's exact test.
Results: The mean age of participants was 42 ± 12 years, and 69.2% were male. Most patients belonged to rural areas (83.5%). Coagulopathy was the most common biochemical abnormality (22.0%), followed by elevated creatine kinase (17.6%), acute kidney injury (14.3%), and thrombocytopenia (13.2%). Complete recovery occurred in 81.3% of patients, while 16.5% developed complications and 2.2% died. Delayed hospital presentation, delayed antivenom administration, acute kidney injury, and the need for dialysis or ventilatory support were significantly associated with adverse outcomes (p<0.05).
Conclusion: Snakebite envenomation is associated with significant biochemical derangements, particularly coagulopathy and acute kidney injury. Early presentation, prompt antivenom administration, and close monitoring are essential to improve clinical outcomes.
References
Afroz A, Siddiquea BN, Chowdhury HA, Jackson TN, Watt AD. Snakebite envenoming: a systematic review and meta-analysis of global morbidity and mortality. PLoS Negl Trop Dis. 2024;18(4): e0012080.
World Health Organization. Snakebite envenoming: a strategy for prevention and control. Geneva: World Health Organization; 2019.
Wang JL. Anti-venom treatment for snakebite envenoming. Nat Rev Dis Primers. 2024;10(1):59.
Gutiérrez JM, Casewell NR, Laustsen AH. Progress and challenges in the field of snakebite envenoming therapeutics. Annu Rev Pharmacol Toxicol. 2025; 65:465-85.
Meena P, Bhargava V, Gupta P, Panda S, Bhaumik S. Kidney injury following snakebite envenomation: a scoping review. BMC Nephrol. 2024; 25:112.
Goumboundi IA, Taylor S, Ayerkain NL, Asum K, Oti MG, Afrifa J, et al. Snake envenomation and acute kidney injury: a systematic review and meta-analysis. BMC Nephrol. 2026; 27:220.
Wood D. Clinical risk factors associated with poor outcomes in snake envenoming: a narrative review. Toxins (Basel). 2023;15(12):675.
Habib AG, Kuznik A, Hamza M, Soyemi K, Onyemelukwe G, Chippaux JP, et al. Snakebite mortality in Nigeria. PLoS Negl Trop Dis. 2015;9(11): e0004088.
Longbottom J, Shearer FM, Devine M, Alcoba G, Chappuis F, Weiss DJ, et al. Vulnerability to snakebite envenoming: a global mapping of hotspots. Lancet. 2018;392(10148):673-84.
Akbar N, Shah SI, Bhatti AA. Clinical outcomes of snake envenomation at Civil Hospital Karachi: a retrospective analysis. Singapore Med J. 2010;51(4):300-04.
Iddi S, Justin J, Hamasaki K, Konje ET, Kongola GW. Assessment of snakebite management practices at Meserani Juu in Monduli District, Northern Tanzania. PLoS One. 2022;17(12): e0278940.
Ahmed S, Koudou GB, Bagot M, Drabo F, Bougma WR, Pulford C, et al. Health and economic burden estimates of snakebite management upon health facilities in three regions of southern Burkina Faso. PLoS Negl Trop Dis. 2021;15(6): e0009464.
Ketor CE, Benneh CK, Mensah KB, Sarkodie E, Mensah A, Somuah SO, et al. Snakebites and antisnake venom utilization in Ghana's Oti region: a 6-year retrospective study. Biomed Res Int. 2024; 2024:6692421.
Warrell DA. Snake bite. Lancet. 2010;375(9708):77-88.
Babo Martins S, Bolon I, Chappuis F, Ray N, Alcoba G, Ochoa C, et al. Snakebite and its impact in rural communities: the need for a One Health approach. PLoS Negl Trop Dis. 2019;13(9):e0007608.
Isbister GK, Maduwage K, Scorgie FE, Shahmy S, Mohamed F, Ismail MM, et al. Venom concentrations and clotting factor levels in a prospective cohort of Russell's viper bites with coagulopathy. PLoS Negl Trop Dis. 2015;9(8): e0003968.
Alves EC, Sachett JAG, Sampaio VS, Sousa JDB, Oliveira SS, Nascimento EFD, et al. Predicting acute renal failure in Bothrops snakebite patients in a tertiary reference center, Western Brazilian Amazon. PLoS One. 2018;13(8): e0202361.
Naqvi R. Snake-bite-induced acute kidney injury. J Coll Physicians Surg Pak. 2016;26(6):517-20.
Mohapatra B, Warrell DA, Suraweera W, Bhatia P, Dhingra N, Jotkar RM, et al. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl Trop Dis. 2011;5(4): e1018.
Patikorn C, Blessmann J, Nwe MT, Tiglao PJG, Vasaruchapong T, Maharani T, et al. Estimating economic and disease burden of snakebite in ASEAN countries using a decision analytic model. PLoS Negl Trop Dis. 2022;16(9): e0010775.
Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017; 3:17063.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Waqar Ahmad, Muhammad Tufail, Aamir Sohail, Hayat Khan , Azam khan , Muhammad Abbas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
